Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease

Published:2018 Issue:47 Volume:33 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Kang Jieun¹^ORCID,Jeong Dae Hyun¹^ORCID,Han Minkyu²^ORCID,Yang Suk-Kyun³^ORCID,Byeon Jeong-Sik³^ORCID,Ye Byong Duk³^ORCID,Park Sang Hyoung³^ORCID,Hwang Sung Wook³^ORCID,Shim Tae Sun¹^ORCID,Jo Kyung-Wook¹^ORCID

Affiliation:

1. Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

2. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Korea.

3. Department of Gastroenterology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2018.33.e292

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis;RMD Open;2024-04

2. Comparative risk of serious infections and tuberculosis in Korean patients with inflammatory bowel disease treated with non-anti-TNF biologics or anti-TNF-α agents: a nationwide population-based cohort study;Therapeutic Advances in Gastroenterology;2024-01

3. RATE OF INFECTION (TUBERCULOSIS) IN BRAZILIANS IBD PRIVATE PATIENTS: FOLLOW-UP 15 YEARS;Arquivos de Gastroenterologia;2024

4. Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications;Biological and Pharmaceutical Bulletin;2023-12-01

5. Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment;PLOS ONE;2022-11-02